Close Menu

    Subscribe to Updates

    Get the latest creative news from Healthradar about News,Health and Gadgets.

    Bitte aktiviere JavaScript in deinem Browser, um dieses Formular fertigzustellen.
    Wird geladen
    What's Hot

    The Garmin Fenix 8 is still at record-low prices, but selling fast – here’s how to get it

    1. Dezember 2025

    The end of malaria: How politics, not parasites, became the biggest threat in the fight against malaria

    1. Dezember 2025

    The Fitbit Charge 6 – a smartwatch I love – drops under $100 at Best Buy

    1. Dezember 2025
    Facebook X (Twitter) Instagram
    Facebook X (Twitter) Instagram Pinterest Vimeo
    healthradar.nethealthradar.net
    • Home
    • Ai
    • Gadgets
    • Health
    • News
    • Contact Us
    Contact
    healthradar.nethealthradar.net
    Home»News»Medtronic wins CE mark for Penditure LAA exclusion device
    News

    Medtronic wins CE mark for Penditure LAA exclusion device

    HealthradarBy Healthradar3. Oktober 2025Keine Kommentare2 Mins Read
    Share Facebook Twitter Pinterest LinkedIn Tumblr Reddit Telegram Email
    Medtronic wins CE mark for Penditure LAA exclusion device
    Share
    Facebook Twitter LinkedIn Pinterest Email


    This audio is auto-generated. Please let us know if you have feedback.

    Dive Brief:

    • Medtronic has received a CE mark for its Penditure left atrial appendage exclusion system, the company said Wednesday.
    • Penditure, which Medtronic acquired and launched in the U.S. in 2023, is a clip that surgeons use to close the LAA during cardiac surgeries. The LAA is a source of stroke-causing clots in patients with atrial fibrillation.
    • AtriCure provides a rival clip that is also implanted during cardiac surgery. Abbott and Boston Scientific sell LAA occlusion devices that are implanted in minimally invasive procedures.

    Dive Insight:

    Medtronic added Penditure to its portfolio through the acquisition of Syntheon. The company launched the device in the U.S. shortly after inking the takeover. This week, Medtronic said it has sold more than 10,000 Penditure devices globally.

    Penditure is a direct competitor of AtriCure’s AtriClip, which the FDA cleared in 2010. AtriClip and Penditure are used in people who are having cardiac surgery for another reason, differentiating them from Abbott’s Amplatzer Amulet and Boston Scientific’s Watchman.

    AtriCure received a CE mark for AtriClip in 2009. The company received CE marks for an updated device and an expanded indication in 2016 and 2024, respectively. International sales of AtriCure’s appendage management products increased 26% over the first six months of the year to hit $20.5 million. U.S. sales of the devices were $87.2 million over the same period.

    Medtronic is now positioned to challenge AtriCure in the European Union and other markets that accept CE marks. In the company’s first quarter of fiscal 2026, Medtronic’s most recent set of results, the company cited Penditure as a driver of low-double digit cardiac surgery growth. 

    The company plans to launch the LAA device in Europe late next week. Medtronic is using the European Association for Cardio-Thoracic Surgery Annual Meeting in Copenhagen, Denmark, to launch the product. The company said Penditure is the only LAA clip that surgeons can recapture, reposition and redeploy after deployment during a procedure.



    Source link

    Device exclusion LAA mark Medtronic Penditure wins
    Share. Facebook Twitter Pinterest LinkedIn Tumblr Email
    Previous ArticleMAHA supporters not on board with Trump’s Pfizer deal
    Next Article Strava just sued Garmin, here’s what that means for the best Garmin watches
    ekass777x
    Healthradar
    • Website

    Related Posts

    News

    Building a better robot: How Virtual Incision plans to challenge Intuitive

    1. Dezember 2025
    News

    Lawmakers propose Medicare reimbursement pathway for AI devices

    26. November 2025
    News

    OIG report finds Medicare overpaying for CGMs and supplies

    26. November 2025
    Add A Comment
    Leave A Reply Cancel Reply

    Top Posts

    Garmin Venu 4: Everything we know so far about the premium smartwatch

    7. August 202576 Views

    The Top 3 Tax Mistakes High-Earning Physicians Make

    7. August 202528 Views

    Linea Expands AI-Powered Heart Failure Care Solution

    6. August 202519 Views

    Zimmer launches 2 devices from $1.1B orthopedic takeover

    10. Oktober 202517 Views
    Stay In Touch
    • Facebook
    • YouTube
    • TikTok
    • WhatsApp
    • Twitter
    • Instagram
    Latest Reviews

    Subscribe to Updates

    Bitte aktiviere JavaScript in deinem Browser, um dieses Formular fertigzustellen.
    Wird geladen
    About Us

    Welcome to HealthRadar.net — your trusted destination for discovering the latest innovations in digital health. We are dedicated to connecting individuals, healthcare professionals, and organizations with cutting-edge tools, applications

    Most Popular

    Garmin Venu 4: Everything we know so far about the premium smartwatch

    7. August 202576 Views

    The Top 3 Tax Mistakes High-Earning Physicians Make

    7. August 202528 Views
    USEFULL LINK
    • About Us
    • Contact Us
    • Disclaimer
    • Privacy Policy
    QUICK LINKS
    • Ai
    • Gadgets
    • Health
    • News
    • About Us
    • Contact Us
    • Disclaimer
    • Privacy Policy
    Copyright© 2025 Healthradar All Rights Reserved.

    Type above and press Enter to search. Press Esc to cancel.